Complex percutaneous coronary intervention in patients unable to undergo coronary artery bypass grafting during the COVID-19 pandemic: insights from the UK-ReVasc Registry

CONCLUSIONS: In patients with patterns of coronary disease in whom CABG would have been the primary therapeutic choice outside of the pandemic, PCI was associated with acceptable outcomes at 12 months of follow-up. Contemporary randomized trials that compare PCI to CABG in such patient cohorts may be warranted.PMID:38471155 | DOI:10.25270/jic/24.00030

Source: The Journal of Invasive Cardiology - March 12, 2024 Category: Cardiology Authors: Thomas A Kite Alexander Chase Colum G Owens Aadil Shaukat Abdul M Mozid Peter O'Kane Helen Routledge Divaka Perera Ajay K Jain Nick Palmer Stephen P Hoole Mohaned Egred Manas K Sinha Thomas J Cahill Brijesh Anantharam Jonathan Byrne Paul D Morris Sharon K Source Type: research